Biotech

All Articles

Lykos 'regrets' not revealing research study transgressions along with author

.Psychopharmacology has pulled three write-ups about midstage professional trial information determi...

Analysts examine Avidity's DMD win, exposing nuances in data

.Avidity Biosciences pleased real estate investors along with period 1/2 information in Duchenne mus...

Actinogen's cortisol blocker falls short stage 2 clinical depression research

.Actinogen Medical's cortisol blocker has overlooked the major endpoint of a phase 2 research study ...

Bivictrix makes a decision going exclusive only technique to take ADC in to facility

.Antibody-drug conjugates (ADCs) have actually gone to the center of several a billion-dollar biobuc...

TPG bests up funds to $580M for assets all over life scientific researches

.Possession manager TPG, which has actually assisted biotechs such as Sionna Rehabs as well as Santa...

Merck ceases phase 3 TIGIT test in lung cancer cells for futility

.Merck &amp Co.'s TIGIT course has actually experienced yet another setback. Months after shuttering...

After a hard year, Exscientia folds in to Recursion

.After a year determined through pipeline cuts, the shift of its chief executive officer and layoffs...

Cullinan, after $25M deal, hands back bispecific to Harbour

.Cullinan Therapy was impressed enough with Port BioMed's bispecific immune system reactor that it e...

A nearer check out Strong Biotech's Ferocious 15

.In this full week's incident of "The Top Pipe," our experts are actually diving in to Ferocious Bio...

Lilly experiences period 2 failing of tau-targeting med

.The confetti is still flying from Eli Lilly's celebration commemorating the approval of Alzheimer's...